News

Biotronik BIOFLEX-I IDE Clinical Trial Puslar-18 Peripheral Artery Disease

Biotronik announced the first U.S. implant of their Pulsar-18 self expanding stent in the BIOFLEX-I IDE clinical trial. Carlos Mena of Yale University Medical Center performed the procedure.

Covidien DEFINITIVE LE Study Peripheral Artery Disease SilverHawk TurboHawk

Covidien announced the completion of enrollment in its DEFINITIVE AR (anti-restenosis) study. As the third study in the DEFINITIVE trial series, this randomized pilot is designed to address the...

April 27, 2012 — GE Healthcare, a unit of General Electric Company, announced the U.S. Food and Drug Administration (FDA) clearance and availability of the latest version of its Vivid E9...

CorPath200 Detroit Medical Center Cardiovascular Institute

The Detroit Medical Center (DMC) announced that a team of heart specialists at its Cardiovascular Institute (CVI) has successfully conducted the Midwest's first-ever "robotic-assisted" coronary...

January 11, 2013 — Guided Interventions LLC, a startup company developing new, easier to use fractional flow reserve (FFR) a product to help cardiologists better assess the physiological impact of...

Angioslide TriVentures Financing Embolic Protection Devices PAD

Angioslide announced the closing of $6.3 million financing led by new investor TriVentures. In addition Biostar joined returning investors Viola Partners, Agate and XT Investments to complete the...

AliveCor Heart Monitor Phone Atrial Fibrillation

The results of a recent study presented yesterday at the American Heart Association Scientific Sessions 2012 conference in Los Angeles showed that a high-quality single-lead ECG can be quickly and...

CardiAQValve Technologies Inc. received $37.3 million in funding in its second round of equity financing. OrbiMed led the round and was joined by Versant Ventures, Advent Life Sciences and...

Spectranetics Upstream Peripheral Technologies Ltd. Peripheral Artery Disease

Spectranetics Corp. announced an agreement to purchase the assets of Upstream Peripheral Technologies Ltd., an affiliate of Aran Research Development and Prototypes Ltd. Included in the...

Abbott Absorb bioresorbable stent

Abbott announced the initiation of the ABSORB III clinical trial in patients in the United States. The randomized controlled trial will enroll about 2,250 patients and compare the performance of...

January 3, 2013 — BioVentrix announced it has received CE mark for its Revivent myocardial anchoring system, which makes possible Less Invasive Ventricular Enhancement (LIVE), a procedure...

Tensys Medical Systems Inc. TL-300 Hemodynamic Monitoring System

Tensys Medical Inc has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the TL-300, the company’s latest generation system. The TL-300 is a member of Tensys’...

The Society of Cardiovascular Computed Tomography (SCCT) announced the publication of the SCCT Expert Consensus Document on Computed Tomography Imaging Before Transcatheter Aortic Valve...

CathPCI Registry Interventional Cardiology Data Cath Lab JACC

A report from the CathPCI Registry, a data registry that includes information from 85 percent of the heart catheterization laboratories in the United States, is providing a vivid snapshot of the...

abbott Xience Xpedition stent

Abbott announced that the Xience Xpedition everolimus-eluting coronary stent system received U.S. Food and Drug Administration (FDA) approval and is launching immediately in the...

Philips Royal Electronics and Unfors RaySafe AB announced the signing of a Joint Development Agreement that will see the development of the next generation Philips DoseAware system, with the aim...

SCAI Ad Hoc PCI Stenting Cath Lab Clinical Trial

When tests reveal that a patient’s heart artery is blocked and blood flow to the heart is restricted, should the doctor fix it with a stent or stop the test and discuss treatment options with the...

TAVR Millenium Market Research Group

According to Millennium Research Group (MRG), approximately 80 percent of transcatheter aortic valve replacement (TAVR) procedures are being performed on high-risk patients who are ineligible for...

Merge Hemo 2012 Best in KLAS Awards: Software & Services hemodynamic monitoring

Merge Healthcare Inc. announced that Merge Hemo has been named the "Category Leader" in the "2012 Best in KLAS Awards: Software & Services" report for Cardiology Hemodynamics rankings for the...

Cerebral Angioplasty Stents Radiology Stroke treatment devices

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.